Can you provide the average price target for IMAX CORP stock?
18 analysts have analysed IMAX and the average price target is 46.36 USD. This implies a price increase of 15.53% is expected in the next year compared to the current price of 40.13.
NYSE:IMAX • CA45245E1097
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IMAX CORP (IMAX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2026-02-26 | Macquarie | Maintains | Outperform -> Outperform |
| 2026-02-26 | Benchmark | Maintains | Buy -> Buy |
| 2026-02-26 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-02-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-24 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-02-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2026-01-26 | Barrington Research | Maintains | Outperform -> Outperform |
| 2026-01-15 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-12-18 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-15 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-12-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-12-08 | Benchmark | Maintains | Buy -> Buy |
| 2025-12-08 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-12-08 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-11-25 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2025-10-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-24 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-10-24 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-24 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-14 | Roth Capital | Maintains | Buy -> Buy |
| 2025-10-09 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-10-09 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-09-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 374.839M 24.61% | 352.208M -6.04% | 410.212M 16.47% | 450.18M 9.74% | 484.08M 7.53% | 513.66M 6.11% | N/A | N/A | |
| EBITDA YoY % growth | 112.762M 78.70% | 111.099M -1.47% | 154.277M 38.86% | 198.99M 28.98% | 226.18M 13.66% | 246.97M 9.19% | 260.53M 5.49% | 281.95M 8.22% | |
| EBIT YoY % growth | 54.547M 565.21% | 47.838M -12.30% | 94.503M 97.55% | 117.17M 23.99% | 137.27M 17.15% | 157.31M 14.60% | 183.2M 16.46% | 204.81M 11.80% | |
| Operating Margin | 14.55% | 13.58% | 23.04% | 26.03% | 28.36% | 30.63% | N/A | N/A | |
| EPS YoY % growth | 0.94 1,242.86% | 0.95 1.06% | 1.44 51.58% | 1.72 19.65% | 2.01 16.56% | 2.29 14.22% | 2.93 27.62% | 3.27 11.85% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.22 65.48% | 0.38 45.19% | 0.50 6.06% | 0.63 8.74% | 0.27 23.38% | 0.45 19.32% | 0.58 15.37% | 0.69 9.40% | 0.28 4.53% | 0.42 -6.70% | 0.54 -5.46% | 0.90 30.99% |
| Revenue Q2Q % growth | 86.932M 0.31% | 104.94M 14.46% | 118.63M 11.23% | 139.91M 11.74% | 90.786M 4.43% | 113.11M 7.79% | 125.57M 5.85% | 153.15M 9.46% | 95.067M 4.72% | 115.93M 2.49% | 118.77M -5.42% | 176.29M 15.11% |
| EBITDA Q2Q % growth | 36.143M 15.30% | 46.656M 2.57% | 56.253M -22.96% | 64.674M -30.25% | 38.07M 5.33% | 51.956M 11.36% | 61.829M 9.91% | 71.462M 10.50% | 44.866M 17.85% | 51.622M -0.64% | 62.706M 1.42% | 89.673M 25.48% |
| EBIT Q2Q % growth | 16.39M -3.96% | 25.067M 57.17% | 35.134M 23.10% | 40.411M 22.65% | 17.144M 4.60% | 36.413M 45.26% | 43.144M 22.80% | 49.468M 22.41% | 27.254M 58.97% | 34.012M -6.59% | 45.095M 4.52% | 72.063M 45.68% |
All data in USD
18 analysts have analysed IMAX and the average price target is 46.36 USD. This implies a price increase of 15.53% is expected in the next year compared to the current price of 40.13.
IMAX CORP (IMAX) will report earnings on 2026-04-23.
The consensus EPS estimate for the next earnings of IMAX CORP (IMAX) is 0.22 USD and the consensus revenue estimate is 86.93M USD.
The expected long term growth rate for IMAX CORP (IMAX) is 7.49%.